SPG vs VTGN · rev $3.55B vs rev $1.3M
SPG (SPG) versus VistaGen Therapeutics Inc (VTGN) — a side-by-side from cached financials, not a winner call.
SPG (SPG) common stock.
VistaGen Therapeutics Inc (VTGN) is a biotechnology company listed on NASDAQ.
Latest reported SPG revenue for 2026-06-30 was $3.55B. Net income was $1.14B. SPG currently screens at market cap $0.
Latest reported VTGN revenue for 2026-03-31 was $1.3M. Net income was -$69.7M. Revenue was up 161.1% from 2025-03-31 to 2026-03-31. VTGN currently screens at market cap $28.1M.
SPG currently screens at market cap $0. VTGN currently screens at market cap $28.1M.
Not investment advice. Open the SPG and VTGN stock pages for the full models.
Not investment advice.